Education
About Us
Working with TipRanks
Follow Us
Q32 Bio (QTTB)
NASDAQ:QTTB
Total Valuation
Q32 Bio has a market cap or net worth of $99.77M. The enterprise value is $50.57M.
Market Cap$99.77M
Enterprise Value$50.57M
Share Statistics
Q32 Bio has 14,629,463 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,629,463
Owned by Insiders2.27%
Owned by Institutions57.79%
Financial Efficiency
Q32 Bio’s return on equity (ROE) is 0.71 and return on invested capital (ROIC) is 29.47%.
Return on Equity (ROE)0.71
Return on Assets (ROA)0.48
Return on Invested Capital (ROIC)29.47%
Return on Capital Employed (ROCE)0.34
Revenue Per Employee1.92M
Profits Per Employee-620.07K
Employee Count28
Asset Turnover0.87
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Q32 Bio is 0.2. Q32 Bio’s PEG ratio is -0.00930.
PE Ratio0.2
PS Ratio0.76
PB Ratio0.97
Price to Fair Value0.97
Price to FCF-1.69
Price to Operating Cash Flow-2.55
PEG Ratio-0.00930
Income Statement
In the last 12 months, Q32 Bio had revenue of 53.74M and earned 29.82M in profits. Earnings per share was 2.42.
Revenue53.74M
Gross Profit53.35M
Operating Income16.90M
Pretax Income29.82M
Net Income29.82M
EBITDA17.29M
Earnings Per Share (EPS)2.42
Cash Flow
In the last 12 months, operating cash flow was -33.54M and capital expenditures 0.00, giving a free cash flow of -33.54M billion.
Operating Cash Flow-33.54M
Free Cash Flow-33.54M
Free Cash Flow per Share-2.29
Dividends & Yields
Q32 Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change211.42%
50-Day Moving Average4.27
200-Day Moving Average2.77
Relative Strength Index (RSI)75.14
Average Volume (3m)396.43K
Important Dates
Q32 Bio upcoming earnings date is May 7, 2026, After Close (Confirmed).
Last Earnings DateMar 10, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Q32 Bio as a current ratio of 4.85, with Debt / Equity ratio of 26.61%
Current Ratio4.85
Quick Ratio4.85
Debt to Market Cap0.25
Net Debt to EBITDA-1.91
Interest Coverage Ratio15.37
Taxes
In the past 12 months, Q32 Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Q32 Bio EV to EBITDA ratio is 0.46, with an EV/FCF ratio of -0.33.
EV to Sales0.15
EV to EBITDA0.46
EV to Free Cash Flow-0.33
EV to Operating Cash Flow-0.33
Balance Sheet
Q32 Bio has $48.30M in cash and marketable securities with $11.18M in debt, giving a net cash position of $37.12M billion.
Cash & Marketable Securities$48.30M
Total Debt$11.18M
Net Cash$37.12M
Net Cash Per Share$2.54
Tangible Book Value Per Share$3.42
Margins
Gross margin is 99.66%, with operating margin of 31.45%, and net profit margin of 55.49%.
Gross Margin99.66%
Operating Margin31.45%
Pretax Margin55.49%
Net Profit Margin55.49%
EBITDA Margin32.18%
EBIT Margin31.45%
Analyst Forecast
The average price target for Q32 Bio is $14.33, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$14.33
Price Target Upside110.12% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast49.57%